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Alterations in general intellectual ability and social cognition in schizophrenia are core 
features of the disorder, evident at the illness’ onset and persistent throughout its course. 
However, previous studies examining cognitive alterations in siblings discordant for 
schizophrenia yielded inconsistent results. Present study aimed to investigate the nature of the 
association between facial emotion recognition and general IQ by applying genetically sensitive 
cross-trait cross-sibling design. Participants (total n=158; patients, unaffected siblings, controls) 
were assessed using the Benton Facial Recognition Test, the Degraded Facial Affect Recognition 
Task (DFAR) and the Wechsler Adult Intelligence Scale-III. Patients had lower IQ and altered 
facial emotion recognition in comparison to other groups. Healthy siblings and controls did not 
significantly differ in IQ and DFAR performance, but siblings exhibited intermediate angry 
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facial expression recognition. Cross-trait within-subject analyses showed significant associations 
between overall DFAR performance and IQ in all participants. Within-trait cross-sibling analyses 
found significant associations between patients’ and siblings’ IQ and overall DFAR 
performance, suggesting their familial clustering. Finally, cross-trait cross-sibling analyses 
revealed familial covariation of facial emotion recognition and IQ in siblings discordant for 
schizophrenia, further indicating their familial etiology. Both traits are important phenotypes for 
genetic studies and potential early clinical markers of schizophrenia-spectrum disorders. 
 




Cognitive alterations (i.e. alterations in general intellectual ability and social cognition) 
seen in patients with schizophrenia are now recognized as a core feature of the disorder (Billeke 
and Aboitiz, 2013; Cannon et al., 2000; Elvevag and Goldberg, 2000). Not specific to the illness’ 
subtypes, they are evident at the onset of the illness (in unmedicated patients), largely state-
independent and persistent in a trait-like fashion, thus potentially reflecting a genetic liability to 
schizophrenia-spectrum disorders. 
The neurodevelopmental hypothesis proposes that cognitive alterations, which may 
represent altered brain development resulting from gene-environment interactions, are likely to 
emerge during childhood/adolescence and to precede full-blown psychosis (Marenco and 
Weinberger, 2000). It is well known that most pre-schizophrenia subjects fail to reach their 
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expected level of general cognitive ability during childhood (Jones et al., 1994) and that general 
IQ alterations characterize a majority of schizophrenia patients throughout the lifespan (Bilder et 
al., 2006; Kremen et al., 2001). Likewise, facial emotion recognition impairment has been 
reported early in the course of schizophrenia, and it is believed to generalize across emotional 
valences with the illness progression (Addington et al., 2006; Kohler et al., 2010).  
Although social cognition requires general cognitive capacities and there may be some 
functional overlap of brain areas underlying social cognition and other more general cognitive 
processes, previous evidence have shown that aforementioned cognitive domains are distinct 
from one another and that social cognitive impairments in schizophrenia are separable from the 
general cognitive ability (Allen et al., 2007; Sergi et al., 2007). Neuroimaging and lesion studies 
have shown that social tasks activate specific brain areas that can be distinguished from those 
activated by non-social tasks, for example superior temporal sulcus, medial prefrontal cortex 
(Adolphs, 2001; Harris et al., 2005; Mitchell et al., 2004), amygdala, fusiform gyrus and insular 
regions (Bar-On R et al., 2003). Consecutively, the MATRICS-NIMH consensus cognitive 
battery for schizophrenia categorized social cognition as one of the seven major separate 
cognitive domains that are altered in schizophrenia, alongside with: Speed of Processing, 
Attention/vigilance, Working Memory, Verbal Learning and Memory, Visual learning and 
Memory and Reasoning and Problem Solving (Green et al., 2004).    
Since it has been shown that some of the healthy siblings of patients with schizophrenia 
also exhibit certain cognitive alterations (i.e. alterations in general IQ and facial emotion 
recognition), it has been proposed that aforementioned cognitive changes might represent 
indicators of vulnerability to schizophrenia-spectrum disorders, deriving from primarily genetic 
(and/or shared environmental) etiologic influences (Cannon et al., 2000; Lavoie et al., 2013). 
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However, previous studies examining cognitive alterations in siblings discordant for 
schizophrenia yielded inconsistent results, and the degree to which these alterations co-segregate 
in schizophrenia-spectrum families have yet to be further investigated. 
Many first degree relatives of schizophrenia patients are predisposing genotype carriers 
without manifesting the disorder phenotypically. Sibling status represents an indirect measure of 
genetic risk since the risk for schizophrenia in those individuals is increased 5- to 10-fold, and 
twin studies have shown that familial clustering is mainly due to genetic factors (Sullivan et al., 
2003). Research in those individuals, deemed to be at different level of genetic risk for 
psychosis, could provide better insight to the pathogenesis of the illness and to indicate potential 
targets for preventive treatments. Thus, it might be worthy investigating familial covariation of 
alterations in general IQ and emotion recognition performance. Both phenotypes have been 
shown to cluster within families, but the nature of the aforementioned relationships is still 
insufficiently evaluated and clarified. It might reflect a shared familiar etiology with a possible 
genetic basis. Alternatively, both IQ and emotion recognition performance might be on a 
common causal pathway or secondary to another factor. 
The present study aimed to investigate whether a shared familial liability may underlie 
the association between facial emotion recognition alteration and general IQ alteration by 
applying genetically sensitive cross-trait cross-sibling design (previously described by GROUP 
investigators Fett et al. (2013) and Lataster et al.
 
(2012)) in a sample comprised of three groups 
of participants with decreasing levels of familial schizophrenia liability (patients, their unaffected 
siblings, healthy controls). Cross-trait cross-sibling analyses allow investigation of an etiological 
association between (subclinical level of expression of) two phenotypes, while removing the 
effects of illness-related factors, such as residual symptoms and medications.  
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At the first step, we explored facial emotion recognition performance and general IQ in 
schizophrenia probands and their unaffected siblings compared to controls. Next step was the 
analysis of the association between facial emotion recognition and general IQ within patient and 
sibling group (cross-trait within subject analysis), to confirm the assumption of the overlap 
between aforementioned domains. Furthermore, we explored familial clustering of general IQ 
and facial emotion recognition performance (within-trait cross-sibling analysis). Finally, we 
explored the associations between patients’ facial emotion recognition performance and siblings’ 
general IQ, and between patients’ IQ and their siblings’ facial emotion recognition ability (cross-
trait cross-sibling analyses). The presence of such associations would be indicative of a shared 
familial etiology of both traits, while finding of associations within patients only would suggest 
that the overlap between lower IQ and impaired facial emotion recognition was rather due to the 
individual factors (i.e. secondary to illness related effects).     
2. Methods 
2.1. Sample and procedure 
Present sample comprised 158 participants originating from Belgrade and surroundings 
catchment area: 52 patients with schizophrenia-spectrum disorders, 55 of their unaffected 
siblings and 51 healthy controls. Patients were recruited from regional mental health institutions, 
unaffected siblings were recruited through participating patients, while control group was 
randomly recruited from the catchment area via local marketing agency. Inclusion criteria for all 
participants were: age ≥ 18 years, IQ ≥ 70, normal vision (or corrected to normal), no recent 
history of alcohol or drug abuse, being able and willing to give informed consent. Patients had to 
meet DSM-IV criteria for psychotic disorder as assessed by Mini International Neuropsychiatric 
Interview (Sheehan et al., 1998), not caused by neurological disorder, currently remitted (GAF 
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score > 40), whereby the illness duration did not exceed 10 years. Additional inclusion criteria 
for unaffected siblings of schizophrenia patients and controls were the absence of personal 
history of psychiatric disorders, and the absence of family history of psychiatric disorders for 
control group only. The study was conducted in accordance with the Declaration of Helsinki and 
its design was approved by the Medical Ethics Committee of the School of Medicine, University 
of Belgrade. All participants gave their written informed consent, and control subjects received 
compensation (vouchers) for their study participation.     
 
2.2. Measures 
The Benton Facial Recognition Test (BFRT)
 
(Benton et al., 1983), an accurate measure 
of the ability to match non-emotional unfamiliar faces, was used for the assessment of 
participants’ general facial recognition ability. Participants were simultaneously presented with 
one target and six other black and white photos of unfamiliar male or female faces with their hair 
and clothing shaded out. Afterwards, they were asked to: (1) match a frontal view of the target 
with an identical photo, (2) match a frontal view of the target face with 3 photos taken from 
different angles, and (3) match a frontal view of the target face with three photos of that person 
taken under different lighting conditions. Total number of correct answers served as main 
outcome parameter.     
The Degraded Facial Affect Recognition Task (DFAR)
 
(Van ‘t Wout et al., 2004) was 
used for the assessment of participants’ ability to recognize four basic emotional facial 
expressions: neutral, happy, fearful and angry. This experimental task consists of 64 face 
presentations (16 in each emotion category) of two male and two female actors depicting 
aforementioned emotions. Visual contrast was reduced by 30% in order to enhance the 
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contribution of interpretation. Main outcome parameters were the percentages of correct answers 
per each facial expresion and the overall percentage of correct answers. 
Wechsler Adult Intelligence Scale- III (WAIS-R)
 
(Velthorst et al., 2013). A brief, 15-
minute, version of the WAIS scale, comprised of subtests Arithmetic, Digit Symbol Coding, 
Information and Block Design, was used to assess participants’ general intellectual ability. It has 
been previously shown that this scale gives reliable estimates of the Full Scale IQ in all three 
groups of participants (patients with schizophrenia-spectrum disorders, their unaffected siblings 
and unrelated healthy controls), thus it was proposed as a useful screening device for general 
intellectual ability in research settings. 
Global Assessment of Functioning scale (GAF)
 
(Hall, 1995). Numeric scale (ranging 
from 0 to 100), designed for the assessment of social and occupational functioning and presence 
of psychiatric symptoms, was used to confirm current remission. 
 
2.3. Statistical analyses 
All statistical analyses were performed using the SPSS version 19 package (Armonk, 
NY: IBM Corp). Initially, all data were tested for normality (Shapiro-Wilks test), and 
accordingly analyzed using appropriate parametric or non-parametric tests. Between group 
differences in socio-demographic characteristics, facial emotion recognition performance and 
general intellectual ability were assessed using chi-square, Mann-Whitney and student’s t-test. 
Partial correlation analyses were used to assess the associations between DFAR performance and 
IQ within all three groups of participants (cross-trait within-subject analyses), familial clustering 
of IQ and facial emotion recognition performance (within-trait cross-sibling analyses), and 
associations between patients’ DFAR performance and siblings’ IQ (cross-trait cross-sibling 
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analyses). As previous research demonstrated that age (Isaacowitz et al., 2007) and gender 
(Donges et al., 2012) have impact on facial emotion recognition performance, their potential 
confounding effect was controlled for in all further analyses. Afterwards, all analyses on DFAR 
performance were adjusted for general facial recognition ability (BFRT). In the cases of families 
contributing with more than one proband or unaffected sibling, all possible sibling pairs were 
analyzed.    
3. Results: 
3.1. Sample characteristics and between-group differences 
Main socio-demographic/clinical characteristics and cognitive performance indices of the 
sample are presented in Table 1. Groups did not differ in terms of age and sex, while significant 
between-group differences were observed in most cognitive tests. Patients showed significantly 
lower IQ and poorer performance on BFRT and DFAR tasks than both their siblings and control 
group. Precisely, in comparison to siblings and controls, schizophrenia patients exhibited 
impaired overall facial emotion recognition (i.e. DFAR total) and impaired recognition of neutral 
and fearful facial expression. Furthermore, patients’ showed significantly poorer recognition of 
angry facial expression than control group only.  
Siblings’ angry facial emotion recognition performance did not significantly differ in 
comparison to other examined groups, but the trend toward significance was evident for both 
patients and controls, suggesting siblings’ intermediate achievement on this task. Descriptive 
statistics revealed significant positive trend for the angry facial expression recognition regarding 
examined groups (when treated as an ordinal variable). However, present sample size was 
insufficient to reveal significant differences between mean level of angry facial expression 
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recognition performance of siblings and patients (1-beta= 41.5%), as well as between siblings 
and controls (1-beta= 33.8%). Significant correlation between groups (in ordered categories) and 
angry facial expression recognition were observed with positive trend (Rho=0.25, p=0.00) 
therefore confirming the possible trend of angry facial expression recognition regarding groups. 
Box plot diagram also revealed positive trend of angry facial expression recognition with regard 
to groups.  
No significant between-group differences in recognizing happy facial expression were 
observed. Despite patients’ overall facial emotion recognition impairment, the valence-related 
performance pattern was similar in all three groups of participants. All participants most 
accurately recognized happy facial expression, followed by neutral, angry and fearful facial 
expression with the lowest rate of correct answers. No significant differences in general IQ and 
facial emotion recognition performance were observed between unaffected siblings and controls. 
Table 2 summarizes between-group differences on the administered cognitive tests. 
 
3.2. Cross-trait within-subject, within-trait cross-sibling and cross-trait cross-sibling analyses 
Table 3 presents all partial correlation analyses (controlled for age and sex) between 
patients’ and siblings’ general IQ and overall facial emotion recognition performance. 
Cross-trait within-subject analyses have revealed significant associations between overall 
DFAR performance and general intellectual ability in all three groups of participants (i.e. 
patients, healthy siblings, controls). Unaffected siblings showed the strongest association 
between aforementioned traits, followed by healthy controls and patients (with the lowest, but 
significant correlation coefficients). After adjusting for general facial recognition ability (BFRT), 
correlation between general IQ and overall DFAR performance remained significant in sibling 
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(r=0.42, p=0.00) and control group (r=0.28, p=0.05), but was no longer significant in the patient 
group (r=0.12, p=0.41). 
Furthermore, within-trait cross-sibling analyses have shown significant associations 
between patients’ and their siblings’ IQ, and between patients’ and siblings’ overall DFAR 
performance as well. This finding was suggestive of significant clustering of facial emotion 
recognition ability and general IQ within families of patients with schizophrenia-spectrum 
disorders.  
Finally, cross-trait cross-sibling analyses have revealed that patients’ overall facial 
emotion recognition performance was significantly correlated with their siblings’ general IQ. 
Moreover, patients’ IQ was also significantly correlated with their siblings’ total DFAR 
performance. All correlations remained significant even after controlling for patients’ and 
siblings’ general facial recognition ability (BFRT). 
 
4. Discussion 
4.1. Facial emotion recognition ability and general IQ over the schizophrenia-spectrum 
continuum 
The present study demonstrated altered processing of emotional information in patients 
with schizophrenia-spectrum disorders in comparison to both their unaffected siblings and 
controls. In line with the earlier evidence related to emotion-specific processing deficits in 
schizophrenia (Allot et al., 2015; Bediou et al., 2007; Fett et al., 2013), we found impaired 
recognition of angry and fearful facial expressions (i.e. negative emotional valence) and 
unimpaired recognition of happy facial expression in the patient group in comparison to sibling 
and control groups. On the other side, contrary to the majority of previous findings, our patient 
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group exhibited impaired recognition of neutral facial expression in comparison to both siblings 
and controls. However, Ruocco et al. (2014) and Kohler et al. (2003) have also reported deficits 
perceiving neutral faces in patients with schizophrenia-spectrum disorders. Possible explanation 
for that finding is aberrant assignment of salience to neutral stimuli that was earlier described in 
psychotic patients (Kapur, 2003). Moreover, studies by Ruocco et al. (2014) and by Eack et al. 
(2010) have demonstrated that individuals at genetic risk of schizophrenia (i.e. siblings) also tend 
to have negative attribution bias (i.e. to misinterpret neutral faces as negative), a finding that we 
did not replicate in our study. Previous studies examining facial emotion recognition in siblings 
discordant for schizophrenia yielded inconsistent results. Some of them reported subtle but 
significant difficulties in facial emotion recognition in unaffected siblings of schizophrenia 
patients (Alfimova et al., 2009; Bediou et al., 2007; Kee et al., 2004), while others have found 
small and non significant differences relative to healthy controls (Cella et al., 2015; Fett et al., 
2013). This variability across studies could be, at least partially, explained by the methodological 
differences between studies (i.e. characteristics of the study subjects, tasks used to assess facial 
emotion recognition). In the present study, siblings’ overall facial emotion recognition 
performance and their ability to recognize fearful and angry facial expressions were somewhat 
lower, although the differences between siblings and controls were small and non significant. 
Nevertheless, angry facial expression recognition ability was distributed along a continuum 
between the patients and controls in our study, with the unaffected siblings showing intermediate 
achievement.   
A similar pattern of achievement was observed for general cognitive ability. Patients’ 
general IQ was significantly lower in comparison to their unaffected siblings and controls. 
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Suggestive of dimensional distribution of general cognitive ability, siblings’ mean IQ was 
slightly lower than controls’, but aforementioned difference did not reach significance.    
Possible explanations for the finding of subtle and insignificant differences in terms of 
emotion recognition performance and general cognitive ability between siblings and control 
subjects are moderate sample size and self-selection bias. Siblings of patients suffering from 
schizophrenia are highly aware of psychotic symptoms, thus it is possible that those who find 
themselves prone to the illness refuse to participate in the study.  
 
4.2. The associations between facial emotion recognition ability and general IQ  
Facial emotion recognition ability was significantly associated with general IQ within all 
three groups of participants (i.e. patients, siblings, controls). Our finding confirmed previous 
ascertainments that general cognitive ability partially accounts for emotion recognition 
performance, but that these two cognitive domains are independent from one another (Sergi et 
al., 2007) since observed correlation coefficients were moderate. 
At this stage of analyses both facial emotion recognition and general IQ were analyzed 
within the same individual. Thus, there was a possibility that one trait was moderated by the 
other trait or that both traits were secondary to some other unobserved traits of that person. 
Moreover, since the association between general IQ and DFAR performance in patient group 
was no longer significant after adjusting for BFRT performance, there was a possibility that 
general facial recognition ability mediated the aforementioned association in patients. Therefore, 
we further conducted a cross-trait cross-sibling analysis, in order to rule out the nature of the 




4.3. Facial emotion recognition performance and general IQ cluster within schizophrenia-
spectrum families 
The within-trait cross-sibling analyses have shown significant familial clustering of both 
general IQ and facial emotion recognition ability. The covariance of those traits within affected 
families means that altered facial emotion recognition and general intellectual ability in patient 
predict alterations in the same cognitive domains in patient’s unaffected sibling. In other words, 
patients with more disturbances in general cognitive ability and facial emotion recognition ability 
tend to also have siblings with more pronounced alterations in those cognitive domains in 
comparison to siblings of cognitively more preserved patients. 
The observed findings might indicate a possible common etiological influences (i.e. genetic 
and/or environmental) underlying impaired facial emotion recognition and general cognitive 
ability in siblings discordant for schizophrenia, since clustering of the aforementioned 
phenotypes has been observed within the affected families. This could be due to shared genes, 
shared environment, or due to the influence of epigenetic factors as well, through the gene-
environment interaction (The European Network of Schizophrenia Networks for the Study of 
Gene-Environment Interactions (EU-GEI), 2008). However, future studies should include the 
control group comprised of healthy pairs of siblings in order to definitely rule out whether the 
observed associations represent phenomenon specific to schizophrenia, or alternatively, whether 
they reflect a general effect of siblings having more similar IQ. 
4.4. Familial covariation of facial emotion recognition ability and general IQ in schizophrenia  
The cross-trait cross-sibling analyses have revealed significant associations between 
patients’ facial emotion recognition ability and siblings’ general IQ, and between patients’ IQ 
and their unaffected siblings’ facial emotion recognition as well. This practically means that 
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patients with worse facial emotion recognition performance tend to have siblings with lower 
general IQ and that patients with more robust cognitive impairment (i.e. lower IQ) tend to have 
siblings with more alterations in facial emotion recognition performance. To our best knowledge, 
this is the first study to date demonstrating significant familial covariation of facial emotion 
recognition ability and general IQ in siblings discordant for schizophrenia, a finding suggesting a 
partially shared etiological pathway underlying both features.  
Cross-trait cross-sibling approach assures that the association between aforementioned 
traits exists in an unconfounded fashion (i.e. removes the effects of illness-related factors), since 
at this stage of analyses facial emotion recognition and general IQ were assessed in different 
individuals (i.e. patients and their siblings). The presence of such familial covariation was 
indicative of a common familial (genetic or environmental) etiology of both traits. Since 
previous research have shown that familial liability to schizophrenia and familial clustering of 
psychosis-related phenotypes mainly represent the influence of shared genes rather than shared 
environment (Cardino et al., 2002; Gur et al., 2007; Linney et al., 2003), alterations in facial 
emotion recognition and general cognitive ability  might represent heritable characteristics of 
schizophrenia. As mentioned earlier, the design of present study does not allow us to conclude 
with certainty whether the association between general IQ and facial emotion recognition is 
specific to schizophrenia, or the same familial covariation might also be observed among siblings 
from the general population.  
Some other mechanisms than those abovementioned may also contribute to the observed 
associations, thus, present findings should be considered in light of their limitations and 
strengths. This is the first study to demonstrate significant familial covariation of facial emotion 
recognition and general IQ in siblings discordant for schizophrenia. The advantage of patient-
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sibling based design is automatic control for potential confounding effects associated with the 
illness (i.e. residual symptoms, medication), and a range of unobserved confounding factors 
given that those subjects share a lot of socio-economic and developmental conditions. An 
important issue in sibling-designed studies is a possibility that some of the unaffected siblings 
use a defensive method of answering, which may cause uncertainty of the obtained data. 
Nevertheless, we constrained this risk by applying objective/experimental tasks, which 
represents the strength of our study. Since approximately two thirds of our patients were 
receiving benzodiazepines, we cannot rule out the possibility that medications influenced their 
performance on time-dependent WAIS-R subscales and DFAR task. However, when linear 
regression analyses were performed, benzodiazepine usage did not predict patients' general IQ 
and overall emotion recognition performance in present research. 
Our results are somewhat limited by the fact that the mean age of unaffected siblings was 
28.6±6.8 years, thus it is possible that not all of them have passed through a window of risk and 
some of them (particularly female subjects) could develop schizophrenia beyond the end of the 
study. Moreover, familial aggregation of traits might be a general phenomenon based on shared 
genetic and/or environmental factors, thus, the best way to explore cross-sibling associations 
based upon common schizophrenia predisposition would be to compare findings observed in 
schizophrenia patients and their siblings with those observed in a healthy group of sibling pairs. 
Therefore, future studies examining familial covariation of certain phenotypes among siblings 
discordant for schizophrenia should include control group comprised of healthy pairs of siblings 
without history of psychotic disorders. Facial emotion recognition alterations might also 
represent trait markers of the proneness to general psychopathology, since those alterations have 
also been observed in other psychiatric disorders (Demenescu et al., 2010; Derntl et al., 2009; 
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Ruocco et al., 2014). Clustering of facial emotion recognition and general intellectual ability is 
also possible in families that have probands with other psychiatric illnesses, which calls for 
further research. Apart from that, familial covariation of the examined features in schizophrenia 
may reflect overlapping neural networks underlying both alterations. The processing of social 
and non-social information relies on semi-independent networks and neurocognitive and social-
cognitive tasks share many cognitive processes, such as working memory and perception. Our 
results indirectly suggest a possible alteration in those neural networks shared by neurocognition 
and social cognition, but this assumption requires confirmation by future functional 
neuroimaging studies.  
Alterations in general IQ and facial emotion recognition performance, particularly angry 
emotion recognition performance, are all associated with liability to schizophrenia spectrum 
disorders and cluster within families. Thus, all these traits represent important intermediary 
phenotypes for genetic studies and potential early clinical markers of schizophrenia-spectrum 
disorders. 
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Table 1 Main socio-demographic/clinical characteristics and cognitive performance indices 
of the sample 
Variable  Patients Siblings Controls p-value
* 
Age (years)  29.33±5.96 28.56±6.82 29.80±6.34 0.56 




12.48±2.06 13.42±2.58 14.00±2.29 0.00* 









62.76±56.72  / / / 
Medication Antipsychotics 52 (100%) / / / 
Mood 
Stabilizers 
16 (30.8%) / / / 
Antidepressants 11 (21.2%) / / / 
Benzodiazepines 34 (65.4%) / / / 
IQ  93.42±13.88 105.47±14.33 107.49±17.50 0.00* 
BFRT
a  21.40±2.29 22.56±2.18 22.75±2.25 0.01* 
DFAR
b
  Total 67.26±13.64 76.94±8.41 78.10±9.60 0.00* 
Neutral 69.49±21.21 80.82±17.00 80.66±16.29 0.00* 
23 
 
Happy 84.75±15.38 89.57±12.14 87.03±10.22 0.10 
Fearful 47.50±23.42 63.55±16.83 66.44±17.14 0.00* 
Angry 67.45±19.54 73.77±16.86 78.83±17.59 0.01* 
Note: Results are presented as mean ± SD and n (%); 
a 
BFRT- The Benton Facial Recognition Task; 
b 
DFAR- The 
Degraded Facial Affect Recognition Task; 
* 
p-values ≤ 0.05 were considered significant; the p-values refer to the 
between-group comparisons across examined groups of participants (patients, siblings, controls). 
 
Table 2 Between-group differences on the administered cognitive tests 










  -4.42 0.00* -4.53 0.00* -0.65 0.52 
BFRT





-3.97 0.00* -4.14 0.00* -0.95 0.34 
Neutral -2.97 0.00* -2.83 0.01* -0.05 0.96 
Happy -1.90 0.06 -0.19 0.85 -1.76 0.08 
Fearful -3.67 0.00* -4.14 0.00* -0.80 0.42 
Angry -1.60 0.11 -2.99 0.00* -1.69 0.09 
Note: 
a
WAIS-R- Wechsler Adult Intelligence Scale- III; 
b
BFRT- The Benton Facial Recognition Task; 
d
DFAR- The Degraded Facial Affect Recognition Task; 
d
Mann-Whitney test (Z) was used to compare 
skewed measures in between-group comparisons (i.e. BFRT, DFAR), while independent-samples t-test 
was used to assess differences in normally distributed variable IQ (WAIS-R); 
* 





Table 3 Partial correlation analyses: cross-trait within-subject, within-trait cross-sibling 
and cross-trait cross-sibling associations 
Analysis Observed association r p 
Cross-trait within-subject 
analysis 
IQ patients – DFARa patients 0.29 0.03* 
IQ siblings – DFARa siblings 0.47 0.00* 
IQ controls – DFARa controls 0.33 0.02* 
Within-trait cross-sibling 
analysis 
IQ patients – IQ siblings 0.29 0.04* 
DFAR
a







 patients – IQ siblings 0.34 0.01* 
IQ patients – DFARa siblings 0.29 0.04* 
Note: all analyses were controlled for Age and Sex; 
a
DFAR- The Degraded Facial Affect 
Recognition Task, total score; 
* 






 Facial emotion recognition and IQ are associated with schizophrenia liability 
 Facial emotion recognition and IQ covariate in sib-pairs discordant for schizophrenia 
 Siblings had intermediate achievement in angry facial expression recognition  
 Objective experimental tasks in sib-pairs study reduce defensive answering risk 
 Cross-trait cross-sibling approach assures unconfounded familial clustering analysis 
 
